Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Relay Therapeutics, Inc. RLAY

Set alert

Price alert · RLAY

All alert types
17.82 USD +0.54 +3.10%

As of Nov 3, 1:51 PM ET

Bid
17.81 × 2
Ask
17.82 × 2
17.28 Day range 18.00
5.95 52-week range 21.27
YTD
+110.58%
1 year
+156.70%
Open
17.47
Prev close
17.28
Mkt cap
3.90B
Vol
1.22M
Avg vol
2.78M
EPS
-1.56
P/E
0.00
Div yield
0.00%
More statistics
Low
17.28
High
18.00
Forward P/E
-10.59
Beta
1.74
Short ratio
13.49
Inst. own
110.87%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
18.52
200-d avg
15.00
1y target
27.58

1D chart

Chart tools
Interval
1m5m15m30m

Signals (64)
NameTimeAgo
MACD: Sell Signal1:38 PM13 minutes ago
SMA: Bearish1:37 PM14 minutes ago
MACD: Buy Signal1:36 PM15 minutes ago
SMA: Bullish1:35 PM16 minutes ago
MACD: Sell Signal1:19 PM32 minutes ago
RSI: Overbought1:03 PM48 minutes ago
RSI: Overbought12:52 PM59 minutes ago
SMA: Bullish12:51 PM1 hour ago
MACD: Buy Signal12:50 PM1 hour ago
MACD: Sell Signal12:34 PM1 hour ago
SMA: Bullish12:29 PM1 hour ago
SMA: Bullish12:29 PM1 hour ago
MACD: Buy Signal12:29 PM1 hour ago
SMA: Bearish12:26 PM1 hour ago
MACD: Sell Signal12:26 PM1 hour ago
SMA: Bullish12:25 PM1 hour ago
MACD: Buy Signal12:25 PM1 hour ago
SMA: Bearish12:22 PM1 hour ago
SMA: Bearish12:22 PM1 hour ago
MACD: Sell Signal12:22 PM1 hour ago

Newest 20 of 64.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 27.58 +54.8% upside
Target (low)
20.00
Target (mean)
27.58
Target (high)
32.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy10
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 13
  • 1 month ago 13
  • 2 months ago 14

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RLAY analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.40119-0.43 – -0.36-0.43+6.7%1.58M0.0%11
Next quarter-0.37949-0.46 – -0.29-0.31-22.4%7.77M+11.0%11
Current year-1.61-1.72 – -1.47-1.61-0.2%11.19M-27.2%11
Next year-1.63-1.83 – -1.11-1.61-1.1%17.91M+60.2%11

Upgrades and downgrades

The latest rating changes

RLAY analyst upgrades and downgrades
DateFirmActionFromTo
Aug 20, 2026HC Wainwright & Co.MaintainedBuyBuy
Aug 14, 2026JP MorganMaintainedOverweightOverweight
Aug 10, 2026CitizensMaintainedMarket OutperformMarket Outperform
Aug 7, 2026BarclaysMaintainedOverweightOverweight
Jul 21, 2026Goldman SachsMaintainedBuyBuy
Jul 16, 2026Canaccord GenuityInitiated—Buy
Jul 8, 2026JP MorganInitiated—Overweight
May 26, 2026GuggenheimMaintainedBuyBuy
May 26, 2026HC Wainwright & Co.MaintainedBuyBuy
May 20, 2026BarclaysMaintainedOverweightOverweight
May 20, 2026CitizensMaintainedMarket OutperformMarket Outperform
May 19, 2026Raymond JamesMaintainedStrong BuyStrong Buy
Apr 29, 2026HC Wainwright & Co.MaintainedBuyBuy
Apr 28, 2026Goldman SachsMaintainedBuyBuy
Apr 28, 2026CitizensMaintainedMarket OutperformMarket Outperform
Apr 28, 2026Wells FargoMaintainedOverweightOverweight
Apr 28, 2026OppenheimerMaintainedOutperformOutperform
Apr 14, 2026Jones TradingInitiated—Hold
Apr 8, 2026BarclaysMaintainedOverweightOverweight
Mar 23, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 17, 2026CitizensMaintainedMarket OutperformMarket Outperform
Mar 17, 2026Wells FargoMaintainedOverweightOverweight
Mar 13, 2026GuggenheimMaintainedBuyBuy
Feb 27, 2026Wells FargoMaintainedOverweightOverweight
Jan 26, 2026OppenheimerUpgradePerformOutperform
Dec 12, 2025Wells FargoUpgradeEqual-WeightOverweight
Nov 7, 2025Wells FargoMaintainedEqual-WeightEqual-Weight
Aug 26, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 8, 2025Raymond JamesMaintainedStrong BuyStrong Buy
May 7, 2025GuggenheimMaintainedBuyBuy